ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Archimica Sells Plant To Teva

April 28, 2008 | APPEARED IN VOLUME 86, ISSUE 17

Germany's Archimica has sold its 5-fluorouracil plant in Puerto Rico to Teva Pharmaceutical Industries of Israel for an undisclosed amount. The final step in a restructuring program that began in late 2006, the sale fits with Archimica's strategy to support only multipurpose facilities for making synthetic building blocks and active pharmaceutical ingredients. Developed in the 1950s as an anticancer agent, 5-fluorouracil was one of the first fluorinated compounds to be used medically.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment